[AGN] Allergan plc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 96.6 B

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 198.87 Change: 4.89 (2.52%)
Ext. hours: Change: 0 (0%)

chart AGN

Refresh chart

Strongest Trends Summary For AGN

AGN is in the long-term up 624% in 20 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well

Fundamental Ratios
Shares Outstanding395.56 M EPS EPS Growth - 4 Quarters115.47% EPS Growth - Q/Q75.5%
EPS Growth - Y/Y58.22% Sales Growth - 4 Quarters 16.06% Sales Growth - Q/Q5.14% P/E
P/E To EPS Growth0.57 P/S13.35 P/BV12.46 Price/Cash Per Share19.45
Price/Free Cash Flow57.37 ROA12.28% ROE19.66% ROI14.05%
Current Ratio4.41 Quick Ratio4.22 Long Term Debt/Equity0.39 Debt Ratio0.2
Gross Margin88.36% Operating Margin27.76% Net Profit Margin21.06% Dividend Payout Ratio-3.91%
Dividend Yield-0.06%
Fundamental Data
Cash From Financing Activities Cash From Investing Activities183.4 M Cash From Operating Activities144.6 M Gross Profit1.7 B
Net Profit694.2 M Operating Profit626.7 M Total Assets12.42 B Total Current Assets6.87 B
Total Current Liabilities1.56 B Total Debt2.09 B Total Liabilities4.66 B Total Revenue1.91 B
Technical Data
High 52 week254.35 Low 52 week163.58 Last close181.33 Last change0.94%
RSI76.15 Average true range4 Beta0.66 Volume3.21 M
Simple moving average 20 days5.72% Simple moving average 50 days5.79% Simple moving average 200 days-14.33%
Performance Data
Performance Week2.38% Performance Month6.1% Performance Quart-2.72% Performance Half-26.68%
Performance Year-14.39% Performance Year-to-date10.85% Volatility daily1.51% Volatility weekly3.37%
Volatility monthly6.91% Volatility yearly23.95% Relative Volume226.12% Average Volume3.42 M
New High New Low

News

2020-05-27 12:56:10 | John Paulson Adds 2 Stocks to Portfolio, Boosts Tiffany

2020-05-26 08:00:15 | AbbVie Wrapped Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?

2020-05-23 20:10:13 | How Hedge Funds Traded Allergan plc AGN Before Its Acquisition

2020-05-22 11:30:11 | John Paulson Trims Allergan, Sprint, Discovery

2020-05-20 08:59:12 | AbbVie, Interactive, Inphi, Chegg and ServiceNow highlighted as Zacks Bull and Bear of the Day

2020-05-20 06:45:10 | Bull of the Day: AbbVie ABBV

2020-05-15 16:20:18 | Jim Simons' Top Buys of the 1st Quarter

2020-05-15 10:45:02 | Pharma Stock Roundup: FDA Updates for LLY, AZN, MRK, BMY and SNY

2020-05-14 17:31:55 | After Drug Failure, Genfit's Cupboard Is Nearly Bare

2020-05-13 07:02:00 | Is AbbVie a Buy Now That the Allergan Deal Is Done?

2020-05-12 12:59:00 | AbbVie Is a Buy as Allergan Deal Closes - A Look at the Charts

2020-05-12 12:10:00 | Form 8.3 - ALLERGAN PLC - Amendment

2020-05-12 08:44:00 | AbbVie Gets Favorable Analyst Reviews After Allergan Merger

2020-05-11 10:43:00 | The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance

2020-05-11 10:15:00 | Form 8.3 - Allergan plc

2020-05-11 08:00:15 | AbbVie Wraps Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?

2020-05-11 06:38:00 | Form 8.3 - ALLERGAN PLC

2020-05-08 16:54:00 | AbbVie closes acquisition of Allergan

2020-05-08 16:20:00 | AbbVie Inc. Completes Acquisition of Allergan plc

2020-05-08 12:38:04 | Editas' EDIT Earnings Beat in Q1, Revenues Improve Y/Y

2020-05-08 05:15:00 | Form 8.3 - ALLERGAN PLC

2020-05-07 10:56:02 | Ironwood IRWD Misses Q1 Earnings and Revenue Estimates

2020-05-07 10:15:00 | Form 8.3 - Allergan plc

2020-05-07 09:00:00 | The Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 Million

2020-05-06 19:23:00 | DexCom & Domino's Pizza Set to Join S&P 500; Salesforce.com to Join S&P 100; STORE Capital to Join S&P MidCap 400; Capri Holdings to Join S&P SmallCap 600

2020-05-06 18:11:21 | Domino's Pizza to join S&P 500, despite pandemic's impact

2020-05-06 10:46:00 | Form 8.3 - Allergan plc - Amendment

2020-05-06 10:23:00 | AbbVie's Pending Acquisition of Allergan Earns FTC Approval

2020-05-06 10:23:00 | AbbVie's Pending Acquisition of Allergan Earns FTC Approval

2020-05-06 08:42:07 | The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle

2020-05-06 08:35:56 | US regulator clears AbbVie’s $63bn deal for Allergan

2020-05-06 08:20:00 | Form 8.3 - Allergan plc

2020-05-06 06:55:00 | Announcement relating to the outcome of the Court Sanction Hearing

2020-05-06 03:38:52 | AbbVie Scores US Antitrust Approval for $63B Allergan Deal

2020-05-05 22:34:28 | AbbVie wins U.S. antitrust approval to buy Allergan

2020-05-05 20:51:56 | PRESS DIGEST- Financial Times - May 6

2020-05-05 18:14:00 | Abbvie's deal for Allergan clears U.S. antitrust hurdle

2020-05-05 18:14:00 | Abbvie's deal for Allergan clears U.S. antitrust hurdle

2020-05-05 17:51:00 | AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie's Acquisition of Allergan

2020-05-05 06:58:00 | Form 8.3 - ALLERGAN PLC

2020-05-04 13:22:52 | David Carlson's Elfun Trusts Cuts Visa, Apple, Microsoft

2020-05-04 10:15:00 | Form 8.3 - Allergan plc

2020-05-04 10:00:15 | AbbVie Reaffirms Plan To Buy Allergan In May — Is AbbVie Stock A Buy?

2020-05-04 09:00:00 | Form 8.3 - Allergan PLC

2020-05-04 07:14:00 | Form 8.3 - Allergan plc - Amendment

2020-05-04 05:42:00 | Form 8.3 - ALLERGAN PLC

2020-05-01 19:14:17 | US Indexes Lower Friday on New Tariff Warnings

2020-05-01 18:16:19 | Dow Jones Tumbles 600 Points on Friday

2020-05-01 16:18:38 | AbbVie's Humira Puts Up Strong Showing, But Allergan Questions Linger

2020-05-01 10:57:02 | AbbVie's ABBV Q1 Earnings and Sales Surpass Estimates